We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Klemens Ruprecht

Klemens Ruprecht MD

Professor and Senior Physician, Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany

Disclosures

Dr. Ruprecht received research support from Novartis Pharma, Merck Serono, German Ministry of Education and Research, European Union (821283-2), Stiftung Charité and Arthur Arnstein Foundation; received speaker honoraria from Bayer and travel grants from Guthy Jackson Charitable Foundation.

Recent Contributions to PracticeUpdate:

  1. NMOSD Biomarker: Serum Glial Fibrillary Acidic Protein